Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ghulam J Mufti

Showing results (121-130 of 224) with videos related to

Pageof 23
Sort By:
Haematologica|December 18, 2012
The effects of 5-azacytidine on the function and number of regulatory T cells and T-effectors in myelodysplastic syndromeBenedetta Costantini, Shahram Y Kordasti, Austin G Kulasekararaj, et al.
Blood|August 21, 2014
Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndromeAustin G Kulasekararaj, Jie Jiang, Alexander E Smith, et al.
Blood|April 7, 2007
CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS)Shahram Y Kordasti, Wendy Ingram, Janet Hayden, et al.
European Journal of Haematology|April 17, 2010
Management and supportive care measures for adverse events in patients with myelodysplastic syndromes treated with azacitidine*Valeria Santini, Pierre Fenaux, Ghulam J Mufti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2011
TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progressionMartin Jädersten, Leonie Saft, Alexander Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2009
Novel TET2 mutations associated with UPD4q24 in myelodysplastic syndromeAzim M Mohamedali, Alexander E Smith, Joop Gaken, et al.
International Journal of Hematologic Oncology|November 29, 2021
A Phase I trial of talazoparib in patients with advanced hematologic malignanciesAjay K Gopal, Rakesh Popat, Ryan J Mattison, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2014
Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemiaJennifer Clay, Austin G Kulasekararaj, Victoria Potter, et al.
British Journal of Haematology|March 30, 2019
Novel ADA2 mutation presenting with neutropenia, lymphopenia and bone marrow failure in patients with deficiency in adenosine deaminase 2 (DADA2)Rohit R Ghurye, Kruthika Sundaram, Frances Smith, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2014
Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: analysis of 533 adult patients who underwent transplantation at King's College HospitalMeng Wang, Wenjia Wang, Ayesha Abeywardane, et al.
Pageof 23

Showing results (121-130 of 224) with videos related to

Sort By:
Pageof 23
Haematologica|December 18, 2012
The effects of 5-azacytidine on the function and number of regulatory T cells and T-effectors in myelodysplastic syndromeBenedetta Costantini, Shahram Y Kordasti, Austin G Kulasekararaj, et al.
Blood|August 21, 2014
Somatic mutations identify a subgroup of aplastic anemia patients who progress to myelodysplastic syndromeAustin G Kulasekararaj, Jie Jiang, Alexander E Smith, et al.
Blood|April 7, 2007
CD4+CD25high Foxp3+ regulatory T cells in myelodysplastic syndrome (MDS)Shahram Y Kordasti, Wendy Ingram, Janet Hayden, et al.
European Journal of Haematology|April 17, 2010
Management and supportive care measures for adverse events in patients with myelodysplastic syndromes treated with azacitidine*Valeria Santini, Pierre Fenaux, Ghulam J Mufti, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 27, 2011
TP53 mutations in low-risk myelodysplastic syndromes with del(5q) predict disease progressionMartin Jädersten, Leonie Saft, Alexander Smith, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 2009
Novel TET2 mutations associated with UPD4q24 in myelodysplastic syndromeAzim M Mohamedali, Alexander E Smith, Joop Gaken, et al.
International Journal of Hematologic Oncology|November 29, 2021
A Phase I trial of talazoparib in patients with advanced hematologic malignanciesAjay K Gopal, Rakesh Popat, Ryan J Mattison, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2014
Nonmyeloablative peripheral blood haploidentical stem cell transplantation for refractory severe aplastic anemiaJennifer Clay, Austin G Kulasekararaj, Victoria Potter, et al.
British Journal of Haematology|March 30, 2019
Novel ADA2 mutation presenting with neutropenia, lymphopenia and bone marrow failure in patients with deficiency in adenosine deaminase 2 (DADA2)Rohit R Ghurye, Kruthika Sundaram, Frances Smith, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 30, 2014
Autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: analysis of 533 adult patients who underwent transplantation at King's College HospitalMeng Wang, Wenjia Wang, Ayesha Abeywardane, et al.
Pageof 23